UnitedHealth Group Incorporated $UNH Shares Sold by Baltimore Washington Financial Advisors Inc.

Baltimore Washington Financial Advisors Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 96.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 751 shares of the healthcare conglomerate’s stock after selling 22,860 shares during the quarter. Baltimore Washington Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $259,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Evexia Wealth LLC increased its holdings in UnitedHealth Group by 34.9% during the 3rd quarter. Evexia Wealth LLC now owns 23,075 shares of the healthcare conglomerate’s stock valued at $8,276,000 after acquiring an additional 5,968 shares in the last quarter. First Trust Advisors LP increased its stake in shares of UnitedHealth Group by 187.9% during the 3rd quarter. First Trust Advisors LP now owns 278,209 shares of the healthcare conglomerate’s stock worth $96,065,000 after purchasing an additional 181,577 shares in the last quarter. Neo Ivy Capital Management purchased a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $3,749,000. Intellectus Partners LLC purchased a new position in UnitedHealth Group during the third quarter worth $740,000. Finally, Foster Dykema Cabot & Partners LLC raised its holdings in shares of UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 34 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $286.86 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The firm’s 50 day moving average is $308.28 and its two-hundred day moving average is $325.83. The company has a market cap of $260.38 billion, a P/E ratio of 21.75, a P/E/G ratio of 1.32 and a beta of 0.41. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the prior year, the firm posted $6.81 EPS. The business’s revenue for the quarter was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th will be paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.1%. The ex-dividend date of this dividend is Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on UNH shares. Oppenheimer dropped their price objective on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a report on Friday, January 30th. UBS Group reduced their price objective on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Barclays cut their price target on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $372.13.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.